Yudai Sato, Tomoko Tadokoro, Hiroki Yamana, Hiraki Akai, Kei Takuma, Naoki Fujita, Mai Nakahara, Kyoko Oura, Koji Fujita, Joji Tani, et al. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report. DEN open. 2024. 4. 1. e265
Tomoko Tadokoro, Kyoko Oura, Kei Takuma, Mai Nakahara, Koji Fujita, Shima Mimura, Joji Tani, Asahiro Morishita, Masafumi Ono, Takashi Himoto, et al. 亜鉛製剤の長期投与中に急激な血球減少・末梢神経障害を生じた肝硬変患者の一例. Kanzo. 2024. 65. 1. 25-30
Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Takashi Himoto, et al. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival. Cancer medicine. 2023
Shima Mimura, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Joji Tani, Asahiro Morishita, Masafumi Ono, Takashi Himoto, et al. Predictors of therapeutic response to peginterferon α-2a and nucleos(t)ide analog combination therapy for HBeAg-negative chronic hepatitis B: 1-year follow-up after treatment. Experimental and therapeutic medicine. 2023. 26. 6. 587-587
Takeshi Hatanaka, Satoru Kakizaki, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, et al. Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed-effects regression model approach. Cancer medicine. 2023